| Application no. and date | 06735838.2 (espacenet) (Federated) (European Patent Register), 20060221 | | Patent/reg. no. and date | DK/EP 1850874, 20131016 | | Publication date | 20071107 | | Priority no. and date | US 655277 P, 20050223 | | EP pub. no. and date |
EP 1850874 20071107 | | Effective date | | | Applicant/owner | Genentech, Inc., 1 DNA Way
South San Francisco CA 94080-4990, US | | Applicant ref. no. | 157806 | | Inventor | DERYNCK, Mika K., 27 Hilltop Road
San Mateo, California 94402, US,
KELSEY, Stephen M., 360 14th Street
Montara, California 94037, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) | | Title | Forlængelse af tid til sygdomsprogression eller overlevelse for ovariecancer ved anvendelse af pertuzumab | | Int. application no. | US2006006334 | | Int. publication no. | WO2006091693 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
